Medicenna Announces Results of Annual General and Special Meeting of Shareholders

· Financial Post

Investor/Company Contact
Daniel Scarr
Director, Corporate Development
Medicenna Therapeutics
[email protected] Read More

Visit saltysenoritaaz.com for more information.

Read full story at source